Ziying Lin

机构：Fujian Medical University, Zhongshan Hospital of Xiamen University · ORCID：0000-0002-9789-8528

发表论文 70 篇 · 总被引 1648 次 · h-index 24

代表论文

• STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer (2023 · Journal for ImmunoTherapy of Cancer · 被引 95)
• Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of EGFR-mutant lung cancer (2023 · Frontiers in Immunology · 被引 32)
• Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer (2022 · Current Pharmaceutical Design · 被引 16)
• A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study (2023 · Clinical Drug Investigation · 被引 13)
• IGF2BP1 restricts the induction of human primordial germ cell fate in an m6A-dependent manner (2025 · Cell stem cell · 被引 8)
• FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K / AKT / mTOR pathway (2024 · Thoracic Cancer · 被引 7)